Systemic Onset Juvenile Idiopathic Arthritis
What's New
Last Posted: Nov 15, 2018
- Novel presentations of periodic fever syndromes: Discrepancies between genetic and clinical diagnoses.
Hoang Tiffany K et al. European journal of rheumatology 2018 Nov 1-7 - Molecular genetic analysis for periodic fever syndromes: a supplemental role for the diagnosis of adult-onset Still's disease.
Li Hongbin et al. Clinical rheumatology 2018 Jun - MEFV mutations in Egyptian children with systemic-onset juvenile idiopathic arthritis.
Lotfy Hala M, et al. Molecular diagnosis & therapy 2014 10 (5) 549-57 - A130: Is the CCR5-delta32 Mutation Protective Against Systemic-Onset Juvenile Idiopathic Arthritis?
Chasnyk Vyacheslav, et al. Arthritis & rheumatology (Hoboken, N.J.) 2014 3 S171 - Association of IRF5 polymorphisms with susceptibility to macrophage activation syndrome in patients with juvenile idiopathic arthritis.
Yanagimachi Masakatsu, et al. The Journal of rheumatology 2011 4 (4) 769-74 - IL10 promoter polymorphisms are associated with systemic onset juvenile idiopathic arthritis (SoJIA).
Möller J C, et al. Clinical and experimental rheumatology 0 0 (6) 912-8 - Systemic onset juvenile idiopathic arthritis
From NCATS Genetic and Rare Diseases Information Center - Mutations in the perforin gene can be linked to macrophage activation syndrome in patients with systemic onset juvenile idiopathic arthritis.
Vastert Sebastiaan J, et al. Rheumatology (Oxford, England) 2010 3 (3) 441-9 - MEFV mutations in systemic onset juvenile idiopathic arthritis.
Ayaz N A, et al. Rheumatology (Oxford, England) 2009 1 (1) 23-5 - Genetic loci contributing to hemophagocytic lymphohistiocytosis do not confer susceptibility to systemic-onset juvenile idiopathic arthritis.
Donn Rachelle, et al. Arthritis and rheumatism 2008 3 (3) 869-74
More
About Rare Diseases PHGKB
Rare Disease PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other information that address the public health impact and translation of genomic and other precision health discoveries into improved health outcomes related to rare diseases...more
Content Summary
Selected Rare Diseases
- Alpha-1 Antitrypsin Deficiency
- Amyotrophic Lateral Sclerosis
- Brugada Syndrome
- Cerebral Palsy
- Cystic Fibrosis
- Duchenne Muscular Dystrophy
- Eclampsia
- Erythema Multiforme
- Familial Mediterranean Fever
- Fragile X Syndrome
- Gaucher Disease
- Glomerulonephritis
- Graves Disease
- Hemophilia
- Huntington Disease
- Microcephaly
- Myasthenia Gravis
- Phenylketonuria
- Retinitis Pigmentosa
- Severe Combined Immunodeficiency
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by Public Health Genomics Branch to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2024
- Content source: